JP2006522062A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006522062A5 JP2006522062A5 JP2006504970A JP2006504970A JP2006522062A5 JP 2006522062 A5 JP2006522062 A5 JP 2006522062A5 JP 2006504970 A JP2006504970 A JP 2006504970A JP 2006504970 A JP2006504970 A JP 2006504970A JP 2006522062 A5 JP2006522062 A5 JP 2006522062A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- dihydro
- benzodiazepine
- dioxolo
- aminophenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0307860.7A GB0307860D0 (en) | 2003-04-04 | 2003-04-04 | Organic compounds |
| PCT/EP2004/003518 WO2004087161A1 (en) | 2003-04-04 | 2004-04-02 | Combinations comprising anti-epileptic drugs for the treatment of neurological disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006522062A JP2006522062A (ja) | 2006-09-28 |
| JP2006522062A5 true JP2006522062A5 (https=) | 2007-05-17 |
Family
ID=9956223
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006504970A Pending JP2006522062A (ja) | 2003-04-04 | 2004-04-02 | 神経学的障害の処置のための抗癲癇剤を含む組み合わせ |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20060194766A1 (https=) |
| EP (1) | EP1620103A1 (https=) |
| JP (1) | JP2006522062A (https=) |
| CN (1) | CN100546581C (https=) |
| AU (1) | AU2004226825B2 (https=) |
| BR (1) | BRPI0409170A (https=) |
| CA (1) | CA2521274A1 (https=) |
| GB (1) | GB0307860D0 (https=) |
| MX (1) | MXPA05010707A (https=) |
| WO (1) | WO2004087161A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060252745A1 (en) | 2005-05-06 | 2006-11-09 | Almeida Jose L D | Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use |
| GB0700773D0 (en) | 2007-01-15 | 2007-02-21 | Portela & Ca Sa | Drug therapies |
| CA2690110A1 (en) * | 2007-07-13 | 2009-01-22 | Eisai R&D Management Co., Ltd. | Ampa receptor antagonists for neuropathic pain |
| WO2009015244A1 (en) * | 2007-07-23 | 2009-01-29 | Synosia Therapeutics | Rufinamide for the treatment of post-traumatic stress disorder |
| US10265311B2 (en) | 2009-07-22 | 2019-04-23 | PureTech Health LLC | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
| PT3061821T (pt) | 2009-07-22 | 2019-09-05 | PureTech Health LLC | Composições para tratamento de distúrbios melhorados por ativação de recetores muscarínicos |
| KR102408292B1 (ko) | 2018-09-28 | 2022-06-10 | 카루나 세러퓨틱스 인코포레이티드 | 무스카린성 수용체 활성화에 의해 개선된 장애의 치료를 위한 조성물 및 방법 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB864536A (en) * | 1957-11-06 | 1961-04-06 | Sapos S A Lab | ª‡-ethyl-phenylacetylurea |
| GB1028234A (en) * | 1964-01-06 | 1966-05-04 | Ici Ltd | New pharmaceutical compositions comprising 5-aminodibenzocycloheptene derivatives |
| JPH02502546A (ja) * | 1987-12-22 | 1990-08-16 | ファーカニー、ジョン ダブリュ | 抗ひきつけ剤組成物および方法のためのデキストロルファン相乗的協力剤 |
| US5095033A (en) * | 1991-03-01 | 1992-03-10 | Laboratoires Biocodex | Method for treating epilepsy |
| IT1261808B (it) * | 1993-07-06 | 1996-06-03 | Impiego di l-carnitina o acido l-carnitine e valproato nel trattamentodei disosrdini convulsivi | |
| EP0946597B1 (en) * | 1996-10-19 | 2003-08-13 | University Of Wales, Bangor | Preparation of chemically reactive starch |
| CA2269807C (en) * | 1996-10-24 | 2007-04-10 | Novartis Ag | Substituted aminoalkanephosphonic acids |
| US6306909B1 (en) * | 1997-03-12 | 2001-10-23 | Queen's University At Kingston | Anti-epileptogenic agents |
| CN1265889A (zh) * | 1999-03-06 | 2000-09-13 | 王学勇 | 一种治疗癫痫病的药物 |
| AR026610A1 (es) * | 1999-12-01 | 2003-02-19 | Ucb Sa | Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central |
| US6191117B1 (en) * | 2000-07-10 | 2001-02-20 | Walter E. Kozachuk | Methods of producing weight loss and treatment of obesity |
| ES2314111T3 (es) * | 2001-11-12 | 2009-03-16 | Novartis Ag | Monohidroxicarbamezepina para uso en la preparacion de un medicamento para el tratamiento del trastorno de afectivo y de atencion y dolor neuropatico. |
-
2003
- 2003-04-04 GB GBGB0307860.7A patent/GB0307860D0/en not_active Ceased
-
2004
- 2004-04-02 CN CNB2004800092188A patent/CN100546581C/zh not_active Expired - Fee Related
- 2004-04-02 MX MXPA05010707A patent/MXPA05010707A/es not_active Application Discontinuation
- 2004-04-02 CA CA002521274A patent/CA2521274A1/en not_active Abandoned
- 2004-04-02 AU AU2004226825A patent/AU2004226825B2/en not_active Ceased
- 2004-04-02 JP JP2006504970A patent/JP2006522062A/ja active Pending
- 2004-04-02 US US10/550,381 patent/US20060194766A1/en not_active Abandoned
- 2004-04-02 WO PCT/EP2004/003518 patent/WO2004087161A1/en not_active Ceased
- 2004-04-02 BR BRPI0409170-1A patent/BRPI0409170A/pt not_active IP Right Cessation
- 2004-04-02 EP EP04725366A patent/EP1620103A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2326881C2 (ru) | Конденсированные производные азолпиримидина, обладающие свойствами ингибитора фосфатидилинозитол-3-киназы (pi3k) | |
| AU2011227398B2 (en) | Modulators of Hec1 activity and methods therefor | |
| ES2638850T3 (es) | Compuestos de azabenzimidazol como inhibidores de las isoenzimas de la PDE4 para el tratamiento de trastornos del SNC y otros trastornos | |
| JP2022536728A5 (https=) | ||
| US20190125745A1 (en) | Treatment and diagnosis of cancer | |
| CN111801339B (zh) | 5-氟尿嘧啶化合物 | |
| AR072688A1 (es) | Nucleosidos y nucleotidos biciclicos como agentes terapeuticos | |
| JP2003513015A5 (https=) | ||
| EP4218935A1 (en) | Lxrbeta agonist for the treatment of cancer | |
| JP2019514950A5 (https=) | ||
| WO2008005956A3 (en) | Pyrrolotriazine kinase inhibitors | |
| RU2006107785A (ru) | 2, 4-пиримидиндиамины, применяемые в лечении неопластических болезней, воспалительных и иммунных расстройств | |
| RU96111418A (ru) | ПРОИЗВОДНЫЕ ПИРИМИДИНДИОНА, ПИРИМИДИНТРИОНА, ТРИАЗИНДИОНА, ТЕТРАГИДРОХИНАЗОЛИНДИОНА В КАЧЕСТВЕ АНТАГОНИСТОВ α1 АДРЕНЕРГИЧЕСКИХ РЕЦЕПТОРОВ | |
| JP2004525149A5 (https=) | ||
| JP2019014758A (ja) | デオキシウリジントリホスファターゼ阻害剤 | |
| NZ594332A (en) | Compounds for the prevention and treatment of cardiovascular disease | |
| JP2017528494A (ja) | ｓＧＣ刺激剤 | |
| JP2004527560A5 (https=) | ||
| JP2006522062A5 (https=) | ||
| WO2008079873A3 (en) | Thiazolyl compounds useful as kinase inhibitors | |
| JP5925680B2 (ja) | キナーゼインヒビター、そのプロドラッグ型および治療におけるそれらの使用 | |
| AU2017207291A1 (en) | Methods for the treatment of myeloid derived suppressor cells related disorders | |
| JP2024504632A (ja) | 非アルコール性脂肪肝疾患および関連する疾患または障害を処置または改善するための化合物、組成物および方法 | |
| MA28583B1 (fr) | Dérivés de pyrimidine pour le traitement d'une croissance cellulaire anormale | |
| JP2022535406A (ja) | Ｐｒｍｔ５阻害剤を使用した癌の治療法 |